Q1 2025 saw stable revenues and a 14.8% increase in order backlog, but EBITDA and net income declined due to exchange losses. The company was listed on the Prague Stock Exchange and adopted IFRS reporting, with major investments in production and R&D.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.